Takehiko Murakami

994 total citations
20 papers, 805 citations indexed

About

Takehiko Murakami is a scholar working on Molecular Biology, Oncology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Takehiko Murakami has authored 20 papers receiving a total of 805 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Oncology and 4 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Takehiko Murakami's work include Bone Metabolism and Diseases (8 papers), Bone health and treatments (7 papers) and Inflammatory mediators and NSAID effects (3 papers). Takehiko Murakami is often cited by papers focused on Bone Metabolism and Diseases (8 papers), Bone health and treatments (7 papers) and Inflammatory mediators and NSAID effects (3 papers). Takehiko Murakami collaborates with scholars based in Japan and United States. Takehiko Murakami's co-authors include Takuhiko Akatsu, Michiko Yamamoto, Naokazu Nagata, Miyuki Nishikawa, Katsuhiro Ono, Kazuo Motoyoshi, Mikio Yamamoto, Nobuo Kugai, Toshio Suda and Shin-ichi Mochizuki and has published in prestigious journals such as The Lancet, The Journal of Clinical Endocrinology & Metabolism and Biochemical and Biophysical Research Communications.

In The Last Decade

Takehiko Murakami

19 papers receiving 789 citations

Peers

Countries citing papers authored by Takehiko Murakami

Since Specialization

Citations

This map shows the geographic impact of Takehiko Murakami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takehiko Murakami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takehiko Murakami more than expected).

Fields of papers citing papers by Takehiko Murakami

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takehiko Murakami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takehiko Murakami. The network helps show where Takehiko Murakami may publish in the future.

Co-authorship network of co-authors of Takehiko Murakami

This figure shows the co-authorship network connecting the top 25 collaborators of Takehiko Murakami. A scholar is included among the top collaborators of Takehiko Murakami based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takehiko Murakami. Takehiko Murakami is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Dipeptidyl Peptidase‐4 Inhibitors Attenuate Endothelial Function as Evaluated by Flow‐Mediated Vasodilatation in Type 2 Diabetic Patients 2013 ·Journal of the American Heart Association ·Makoto Ayaori, Naotsugu Iwakami, Harumi Uto‐Kondo, Hiroki Sato, Makoto Sasaki, Tomohiro Komatsu, Maki Iizuka, Shunichi Takiguchi, Emi Yakushiji, Kazuhiro Nakaya, Makiko Yogo, Masatsune Ogura, Bonpei Takase, Takehiko Murakami, Katsunori Ikewaki	107
2	[A case of follicular lymphoma with onset of chylothorax]. 2007 ·PubMed ·Noboru Hanaoka, (unknown), Takehiko Murakami, (unknown), Toshiyuki Suganuma	2
3	2007 ·Journal of The Japan Institute of Electronics Packaging ·Takehiko Murakami	0
4	A Family of Autosomal Dominant Hypocalcemia with a Positive Correlation between Serum Calcium and Magnesium: Identification of a Novel Gain of Function Mutation (Ser⁸²⁰Phe) in the Calcium-Sensing Receptor 2002 ·The Journal of Clinical Endocrinology & Metabolism ·Terumasa Nagase, Takehiko Murakami, Toshihiko Tsukada, Ryuichi Kitamura, Noriko Chikatsu, (unknown), Nobuki Takata, Hiroko Yasuda, Seiji Fukumoto, Yuji Tanaka, Naokazu Nagata, Ken Yamaguchi, Takuhiko Akatsu, Michiko Yamamoto	15
5	Involvement of Cyclo-Oxygenase-2 in Osteoclast Formation and Bone Destruction in Bone Metastasis of Mammary Carcinoma Cell Lines 2002 ·Journal of Bone and Mineral Research ·Katsuhiro Ono, Takuhiko Akatsu, Takehiko Murakami, Ryuichi Kitamura, Michiko Yamamoto, Nariyoshi Shinomiya, Makoto Rokutanda, Tomoyo Sasaki, Norio Amizuka, Hidehiro Ozawa, Naokazu Nagata, Nobuo Kugai	56
6	High blood pressure lowered by pregnancy 2000 ·The Lancet ·Takehiko Murakami, (unknown), Yuji Tanaka, Michiko Yamamoto	15
7	Direct metal analyses of Mn²⁺‐dependent and ‐independent protein phosphatase 2A from human erythrocytes detect zinc and iron only in the Mn²⁺‐independent one 1999 ·FEBS Letters ·Yasumasa Nishito, Hirofumi Usui, Kyoko Shinzawa‐Itoh, Rintaro Inoue, Osamu Tanabe, (unknown), Takehiko Murakami, Masao Takeda	19
8	Hepatic Metabolic Clearance of Midazolam, a Cytochrome P450 3A Substrate, in the Presence of Ketoconazole in Rats 1999 ·Pharmacy and Pharmacology Communications ·Fumiko Higashikawa, Takehiko Murakami, (unknown), Mikihisa Takano	2
9	Hypocalcemic Effect of Osteoclastogenesis Inhibitory Factor/Osteoprotegerin in the Thyroparathyroidectomized Rat 1998 ·Endocrinology ·Michiko Yamamoto, Takehiko Murakami, Miyuki Nishikawa, Toshio Suda, Shin-ichi Mochizuki, Kanji Higashio, Takuhiko Akatsu, Kazuo Motoyoshi, Naokazu Nagata	39
10	Transforming Growth Factor-β1 Increases mRNA Levels of Osteoclastogenesis Inhibitory Factor in Osteoblastic/Stromal Cells and Inhibits the Survival of Murine Osteoclast-like Cells 1998 ·Biochemical and Biophysical Research Communications ·Takehiko Murakami, Michiko Yamamoto, Mikio Yamamoto, Katsuhiro Ono, Miyuki Nishikawa, Naokazu Nagata, Kazuo Motoyoshi, Takuhiko Akatsu	164
11	Osteoclastogenesis inhibitory factor exhibits hypocalcemic effects in normal mice and in hypercalcemic nude mice carrying tumors associated with humoral hypercalcemia of malignancy 1998 ·Bone ·Takuhiko Akatsu, Takehiko Murakami, Kohei Ono, Masanobu Nishikawa, Toshio Suda, Shin-ichi Mochizuki, Nobuaki Fujise, Kanji Higashio, K Motoyoshi, Michiko Yamamoto, Noriko Nagata	64
12	Osteoclastogenesis Inhibitory Factor Suppresses Osteoclast Survival by Interfering in the Interaction of Stromal Cells with Osteoclast 1998 ·Biochemical and Biophysical Research Communications ·Takuhiko Akatsu, Takehiko Murakami, Miyuki Nishikawa, Katsuhiro Ono, Nariyoshi Shinomiya, Toshio Suda, Shin-ichi Mochizuki, Kyoji Yamaguchi, Masahiko Kinosaki, Kanji Higashio, Michiko Yamamoto, Kazuo Motoyoshi, (unknown)	106
13	Effect of acarbose on postprandial lipid metabolism in type 2 diabetes mellitus 1998 ·Diabetes Research and Clinical Practice ·Seijiro Kado, Takehiko Murakami, Akira Aoki, Terumasa Nagase, Yoshiya Katsura, Masayuki Noritake, Takeshi Matsuoka, (unknown)	45
14	Mouse Mammary Carcinoma Cell Line (BALB/c-MC) Stimulates Osteoclast Formation From Mouse Bone Marrow Cells Through Cell-to-Cell Contact 1998 ·Bone ·Kohei Ono, Takuhiko Akatsu, Takehiko Murakami, Seiki Wada, Masanobu Nishikawa, Nobuo Kugai, Michiko Yamamoto, Nariaki Matsuura∥, Noriko Nagata	13
15	A Third-Generation Bisphosphonate, YM175, Inhibits Osteoclast Formation in Murine Cocultures by Inhibiting Proliferation of Precursor Cells via Supporting Cell-Dependent Mechanisms 1998 ·Journal of Bone and Mineral Research ·Miyuki Nishikawa, Michiko Yamamoto, Takehiko Murakami, Takuhiko Akatsu, Nobuo Kugai, Naokazu Nagata	12
16	Important role of EP4, a subtype of prostaglandin (PG) E receptor, in osteoclast-like cell formation from mouse bone marrow cells induced by PGE2 1998 ·Journal of Endocrinology ·Kohei Ono, Takuhiko Akatsu, Takehiko Murakami, Masanobu Nishikawa, Masahide Yamamoto, Nobuo Kugai, (unknown), Noriko Nagata	40
17	Chinese Hamster Ovary Cells Expressing α4β1 Integrin Stimulate Osteoclast Formation In Vitro 1998 ·Journal of Bone and Mineral Research ·Takuhiko Akatsu, Katsuhiro Ono, Takehiko Murakami, Yasuyuki Katayama, Miyuki Nishikawa, Seiki Wada, Michiko Yamamoto, Nobuo Kugai, Nariaki Matsuura∥, Yoshikazu Takada, Naokazu Nagata	9
18	Tissue and Subcellular Distributions, and Characterization of Rat Brain Protein Phosphatase 2A Containing a 72-kDa /B'' Subunit 1997 ·The Journal of Biochemistry ·(unknown), Takehiko Murakami, Hirōshi Nozaki, Rintaro Inoue, Yasumasa Nishito, Osamu Tanabe, Hiroyuki Usui, Masao Takeda	23
19	Molecular cloning of a 74‐kDa regulatory subunit (B″ or δ) of human protein phosphatase 2A 1996 ·FEBS Letters ·Osamu Tanabe, (unknown), Takehiko Murakami, (unknown), Hirofumi Usui, Yasumasa Nishito, Hideyuki Hayashi, Hiroyuki Kagamiyama, Masao Takeda	44
20	Thyroid Dysfunction in isolated Adrenocorticotropic Hormone (ACTH) Deficiency: Case Report and Literature Review. 1993 ·Endocrine Journal ·Takehiko Murakami, Seiki Wada, Yasuyuki Katayama, Yoko Nemoto‐Sasaki, Nobuo Kugai, Naokazu Nagata	30

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact